Sandra Moore
- Genetics top 0.5%
- Myeloproliferative Neoplasms: Diagnosis and Treatment 6
- Hematology top 1%
- Acute Myeloid Leukemia Research 3
- Chronic Myeloid Leukemia Treatments 2
- Rheumatology top 2%
- Eosinophilic Disorders and Syndromes 5
- Molecular Biology top 10%
- Kruppel-like factors research 2
- Protein Degradation and Inhibitors 1
- Oncology top 10%
- Cytokine Signaling Pathways and Interactions 2
-
- Neonatal and fetal brain pathology 1
- Co-authors
- Benjamin H. LeeD. Gary GillilandRoss L. LevineThomas MercherGerlinde WernigElizabeth McDowellMaricel GozoYana Pikman
- Cited by
- GeneticsHematologyRheumatology
- Partner nations
- United StatesSwitzerlandGermany
In The Last Decade
Sandra Moore
11 papers receiving 1.7k citations
Hit Papers
Peers
Comparison fields: 5 of 66
- Genetics 1.3k
- Hematology 1.1k
- Rheumatology 445
- Molecular Biology 978
- Oncology 254
Countries citing papers authored by Sandra Moore
This map shows the geographic impact of Sandra Moore's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sandra Moore with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sandra Moore more than expected).
Fields of papers citing papers by Sandra Moore
This network shows the impact of papers produced by Sandra Moore. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sandra Moore. The network helps show where Sandra Moore may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Sandra Moore, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 4 | |
| 2 | 2015 | 54 | |
| 3 | 2010 | 31 | |
| 4 | 2009 | 73 | |
| 5 | 2009 | 60 | |
| 6 | 2008 | 305 | |
| 7 | 2008 | 101 | |
| 8 | 2007 | 10 | |
| 9 | MPLW515L Is a Novel Somatic Activating Mutation in Myelofibrosis with Myeloid Metaplasiabreakdown → | 2006 | 1024 |
| 10 | 2005 | 72 | |
| 11 | 2004 | 1 |
About Sandra Moore
Sandra Moore is a scholar working on Genetics, Hematology and Rheumatology, having authored 11 papers that have together received 1.7k indexed citations. Recurring topics across this work include Myeloproliferative Neoplasms: Diagnosis and Treatment (6 papers), Eosinophilic Disorders and Syndromes (5 papers), Acute Myeloid Leukemia Research (3 papers), Chronic Myeloid Leukemia Treatments (2 papers), Kruppel-like factors research (2 papers), Cytokine Signaling Pathways and Interactions (2 papers), Neonatal and fetal brain pathology (1 paper) and Protein Degradation and Inhibitors (1 paper). The work is most often cited by research in Genetics (1.3k citations), Hematology (1.1k citations) and Rheumatology (445 citations). Sandra Moore has collaborated with scholars based in United States, Switzerland and Germany. Frequent co-authors include Benjamin H. Lee, D. Gary Gilliland, Ross L. Levine, Thomas Mercher, Gerlinde Wernig, Elizabeth McDowell, Maricel Gozo, Yana Pikman, Ilene Galinsky and Martha Wadleigh. Their work appears in journals such as Blood, PLoS Medicine, European Journal of Human Genetics, Cell stem cell and Clinical Genetics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.